BCLI
Companies
NASDAQ
Brainstorm Cell Therapeutics Inc.
Health Care
$1.19
-$1.05 (-46.04%)
Price Chart
Overview
About BCLI
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.
Market Cap
$28.8M
Volume
44.7K
Avg. Volume
40.7K
P/E Ratio
-0.4878049
Dividend Yield
0.00%
Employees
26.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.76
Moderate Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, BCLI shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025